BIOC Insider Trading

Notice: This stock is marked as potentially delisted. It may not be actively trading.
Insider Ownership Percentage: 1.61%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00

Biocept Insider Trading History Chart

This chart shows the insider buying and selling history at Biocept by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Biocept Share Price & Price History

Current Price: $0.00
Price Change: +0.30 (1.20%)
As of 10/25/2023 12:59 AM ET

This chart shows the closing price history over time for BIOC up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table

Biocept Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/9/2021David F. HaleDirectorSell2$122.10$244.20View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Biocept (NASDAQ:BIOC)

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at BIOC by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Biocept Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/15/2023Boothbay Fund Management LLC23,529$28K0.0%N/A3.988%Search for SEC Filing on Google Icon
8/14/2023Anson Funds Management LP44,861$54K0.0%N/A7.604%Search for SEC Filing on Google Icon
11/15/2022Vanguard Group Inc.617,610$0.57M0.0%-5.8%3.620%Search for SEC Filing on Google Icon
8/15/2022Millennium Management LLC103,124$97K0.0%N/A0.609%Search for SEC Filing on Google Icon
8/13/2022Renaissance Technologies LLC175,500$0.17M0.0%+50.8%1.037%Search for SEC Filing on Google Icon
5/13/2022Renaissance Technologies LLC116,400$0.27M0.0%+27.1%0.689%Search for SEC Filing on Google Icon
5/12/2022Acadian Asset Management LLC26,582$61K0.0%-57.3%0.157%Search for SEC Filing on Google Icon
4/18/2022Taylor & Morgan Wealth Management LLC23,000$53K0.0%+91.7%0.136%Search for SEC Filing on Google Icon
2/14/2022PDT Partners LLC35,901$0.13M0.0%N/A0.213%Search for SEC Filing on Google Icon
2/10/2022Bailard Inc.42,100$0.15M0.0%N/A0.250%Search for SEC Filing on Google Icon
2/10/2022Acadian Asset Management LLC62,319$0.23M0.0%N/A0.370%Search for SEC Filing on Google Icon
2/10/2022Globeflex Capital L P233,578$0.85M0.2%-27.2%1.387%Search for SEC Filing on Google Icon
1/21/2022Taylor & Morgan Wealth Management LLC12,000$43K0.0%N/A0.071%Search for SEC Filing on Google Icon
11/15/2021Marshall Wace LLP104,980$0.42M0.0%N/A0.713%Search for SEC Filing on Google Icon
11/15/2021GSA Capital Partners LLP92,639$0.37M0.0%-38.9%0.629%Search for SEC Filing on Google Icon
11/12/2021Jump Financial LLC19,500$78K0.0%N/A0.132%Search for SEC Filing on Google Icon
9/17/2021Virtu Financial LLC19,004$80K0.0%N/A0.129%Search for SEC Filing on Google Icon
8/16/2021State Street Corp37,996$0.16M0.0%N/A0.283%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC134,851$0.57M0.0%+2.4%1.006%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.658,586$2.76M0.0%-1.3%4.914%Search for SEC Filing on Google Icon
8/5/2021GSA Capital Partners LLP151,532$0.64M0.1%+288.1%1.131%Search for SEC Filing on Google Icon
5/13/2021Trexquant Investment LP10,204$52K0.0%N/A0.076%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC131,728$0.67M0.0%+52.2%0.983%Search for SEC Filing on Google Icon
5/10/2021GSA Capital Partners LLP39,046$0.20M0.0%N/A0.291%Search for SEC Filing on Google Icon
5/3/2021Hussman Strategic Advisors Inc.72,000$0.37M0.1%+1,957.1%0.537%Search for SEC Filing on Google Icon
4/27/2021Belvedere Trading LLC75,444$0.38M0.0%N/A0.563%Search for SEC Filing on Google Icon
2/24/2021Virtu Financial LLC14,647$65K0.0%N/A0.109%Search for SEC Filing on Google Icon
2/9/2021Bank of New York Mellon Corp16,243$72K0.0%N/A0.121%Search for SEC Filing on Google Icon
11/6/2020BlackRock Inc.191,630$0.85M0.0%-92.3%1.431%Search for SEC Filing on Google Icon
11/2/2020Hussman Strategic Advisors Inc.83,500$0.37M0.1%N/A0.623%Search for SEC Filing on Google Icon
8/12/2020Hudson Bay Capital Management LP37,037$26K0.0%N/A0.028%Search for SEC Filing on Google Icon
2/13/2020Renaissance Technologies LLC457,744$0.13M0.0%N/A0.961%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Biocept logo
Biocept, Inc., a molecular oncology diagnostics company, develops and commercializes proprietary clinical diagnostic laboratory assays designed to identify rare tumor cells and cell-free tumor DNA from blood and cerebrospinal fluid, or CSF in the United States. Its cancer assays provide information to healthcare providers to identify oncogenic alterations that qualify a subset of cancer patients for targeted therapy at diagnosis, progression, and monitoring to identify resistance mechanisms. The company offers assays for solid tumor indications, such as breast cancer, non-small cell lung cancer (NSCLC), gastric cancer, colorectal cancer, prostate cancer, pancreaticobiliary cancer, and ovarian cancer. It also provides cerebrospinal fluid tumor cell and ctDNA and ctRNA testing services to medical oncologists, neuro-oncologists, surgical oncologists, radiation oncologists, urologists, pulmonologists, pathologists, and other physicians; and clinical trial and research services to pharmaceutical companies, biopharmaceutical companies and clinical research organizations. The company has a collaboration with CLEARED4 to develop a system for tracking and managing COVID-19 testing requirements and test results for its customers; and with Protean BioDiagnostics, Inc. to research the ability of its Target Selector molecular assay to determine EGFR status in NSCLC patients. Biocept, Inc. was incorporated in 1997 and is headquartered in San Diego, California. On October 13, 2023, Biocept, Inc. filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the District of Delaware.
Read More on Biocept

Today's Range

Now: N/A

50 Day Range

MA: $0.97
Low: $0.43
High: $1.67

52 Week Range

Now: N/A

Volume

751,400 shs

Average Volume

764,067 shs

Market Capitalization

$1.14 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.69

Who are the major institutional investors of Biocept?

Biocept's top institutional investors include:
  1. Concourse Financial Group Securities Inc. — 0.00%
Learn More about top institutional investors of Biocept stock.